303 related articles for article (PubMed ID: 3486919)
1. Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus.
Meryhew NL; Kimberly RP; Messner RP; Runquist OA
J Immunol; 1986 Jul; 137(1):97-102. PubMed ID: 3486919
[TBL] [Abstract][Full Text] [Related]
2. Mononuclear phagocyte function in SLE. I. Bipartite Fc- and complement-dependent dysfunction.
Kimberly RP; Meryhew NL; Runquist OA
J Immunol; 1986 Jul; 137(1):91-6. PubMed ID: 3011912
[TBL] [Abstract][Full Text] [Related]
3. Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor-ligand binding and internalization.
Salmon JE; Kimberly RP; Gibofsky A; Fotino M
J Immunol; 1984 Nov; 133(5):2525-31. PubMed ID: 6481162
[TBL] [Abstract][Full Text] [Related]
4. [Fc-receptor mediated immune complex clearance function of the mononuclear phagocyte system in systemic lupus erythematosus].
Kästner P; Franke H; Kleinert P; Günther C; Malberg K; Löbnitz M
Allerg Immunol (Leipz); 1990; 36(2):103-10. PubMed ID: 2392958
[TBL] [Abstract][Full Text] [Related]
5. Reticuloendothelial Fc receptor function in SLE patients. I. Primary HLA linked defect or acquired dysfunction secondary to disease activity?
van der Woude FJ; van der Giessen M; Kallenberg CG; Ouwehand W; Beekhuis H; Beelen JM; van Son WJ; Hoedemaeker PJ; van der Hem GK; The TH
Clin Exp Immunol; 1984 Mar; 55(3):473-80. PubMed ID: 6584255
[TBL] [Abstract][Full Text] [Related]
6. Monocyte receptors for the Fc portion of IgG are increased in systemic lupus erythematosus.
Fries LF; Mullins WW; Cho KR; Plotz PH; Frank MM
J Immunol; 1984 Feb; 132(2):695-700. PubMed ID: 6228597
[TBL] [Abstract][Full Text] [Related]
7. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus.
Frank MM; Hamburger MI; Lawley TJ; Kimberly RP; Plotz PH
N Engl J Med; 1979 Mar; 300(10):518-23. PubMed ID: 763252
[TBL] [Abstract][Full Text] [Related]
8. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
Arora V; Verma J; Dutta R; Marwah V; Kumar A; Das N
Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
[TBL] [Abstract][Full Text] [Related]
9. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
Greisman SG; Redecha PB; Kimberly RP; Christian CL
J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531
[TBL] [Abstract][Full Text] [Related]
10. Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE).
Hurst NP; Nuki G; Wallington T
Clin Exp Immunol; 1984 Feb; 55(2):303-12. PubMed ID: 6697566
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal study of circulating immune complexes, dna antibodies and complement in patients with systemic lupus erythematosus: an analysis of their relationship to disease activity.
Harkiss GD; Hazleman BL; Brown DL
J Clin Lab Immunol; 1979 Nov; 2(4):275-83. PubMed ID: 537024
[TBL] [Abstract][Full Text] [Related]
12. Immune complex clearance by monocytes and macrophages in systemic lupus erythematosus.
Kavai M; Szegedi G
Autoimmun Rev; 2007 Aug; 6(7):497-502. PubMed ID: 17643939
[TBL] [Abstract][Full Text] [Related]
13. Monocyte in vitro function in systemic lupus erythematosus (SLE). I. A clinical and immunological study.
Svensson B
Scand J Rheumatol Suppl; 1980; 31():29-41. PubMed ID: 6992266
[TBL] [Abstract][Full Text] [Related]
14. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
Davis P; Cumming RH; Verrier-Jones J
Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
[TBL] [Abstract][Full Text] [Related]
15. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
16. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
[TBL] [Abstract][Full Text] [Related]
17. DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q.
Bengtsson A; Nezlin R; Shoenfeld Y; Sturfelt G
J Autoimmun; 1999 Aug; 13(1):111-9. PubMed ID: 10441175
[TBL] [Abstract][Full Text] [Related]
18. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
19. Reticuloendothelial system Fc receptor function in systemic lupus erythematosus.
Kabbash L; Brandwein S; Esdaile J; Danoff D; Fuks A; Shuster J
J Rheumatol; 1982; 9(3):374-9. PubMed ID: 7120232
[TBL] [Abstract][Full Text] [Related]
20. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
